| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC1670 |
| Trial ID | NCT02959151 |
| Disease | Hepatocellular Carcinoma | Pancreatic Cancer | Colorectal Cancer |
| Altered gene | GPC3|MESO|CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPC3/Mesothelin/CEA CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy |
| Year | 2016 |
| Country | China |
| Company sponsor | Shanghai GeneChem Co., Ltd. |
| Other ID(s) | CAR-T for liver cancer |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||